Skip to main content
. 2023 Feb 1;10(2):1280–1293. doi: 10.1002/ehf2.14275

Figure 2.

Figure 2

Association of medication dose categories at 6 months with 1 year composite outcome (inversely weighted for probability of achieving ≥50% guideline‐recommended dose). BBL, beta‐blocker; HR, hazard ratio; RASi, renin–angiotensin system inhibitor.